What Is the First-Line Treatment for Cervical Dystonia?

This protocol covers the structured, evidence-based first-line approach to managing cervical dystonia, addressing the injection strategy, instrumental guidance, and combination with rehabilitation.

Treatment Approach

First-line management centres on botulinum neurotoxin type A (BoNT-A) injection, individualised to the patient's clinical presentation and combined with specific rehabilitation measures — the complete injection strategy, guidance technique, and combination protocol are set out in the full regimen below.

Treatment Goals

Clinical improvement of cervical dystonia is the primary endpoint, evaluated between 4 and 6 weeks after the initial treatment.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3390/toxins18020079

Among pharmacological treatments, botulinum neurotoxin represents the first-line treatment for patients with CD.
At first inoculation, it is recommended to treat only the prevailing dystonic pattern.
To optimize treatment, it is recommended to use instrumental guidance.
It is advisable to combine physiotherapy with toxin treatment.
It is advisable to combine self-rehabilitation with toxin treatment.
It is advisable to combine psychological treatment with toxin treatment in patients with emotional distress.
After the first treatment, it is necessary to evaluate the effectiveness of the treatment between 4 and 6 weeks after inoculation.

View source ↗